Computational docking is an essential tool for analysis of biomolecular structure and function and for the discovery and development of new bioactive compounds. In particular, virtual screening is now widely used to discover new compounds to bind and inhibit targets of medicinal interest. The AutoDock Suite of programs is currently the most widely used, freely-available method for automated computational docking. This success is the result of several aspects of the work performed under the previous granting period: the continued development of the method to address problems of interest in the community, such as covalent docking and active site prediction, and the development of user-friendly interfaces and user support that ensure that the method is accessible to the widest community possible. As a result of this work, we have seen adoption and extension of the AutoDock suite by expert users, using the suite as a platform for research in computational chemistry and algorithm development, in parallel with widespread application by experimental chemists and molecular biologists who are not experts in computational chemistry. In the proposed work, we will develop AutoDock into a next generation tool for drug design and discovery. This will include extensions of the methods of AutoDock to address the expanding and varied needs of a large user community. We will develop new methods for ligand design that allow to generate novel compounds, employing specific constraints that will ensure that such compounds are synthetically accessible, and predicted to have desirable pharmacological properties. We will also continue and expand our strong commitment to user support, creating interfaces that streamline use of the AutoDock suite by the user community, and providing effective support and training.

Public Health Relevance

Computational docking and virtual screening have lead to the discovery of numerous new drugs for fighting disease. We will expand the most popular software for computational docking, the AutoDock suite, to create an advanced environment for docking and drug design. This will include development of new methods for predicting bound conformations and association energies, novel strategies for drug discovery and refinement, and creation of a user-friendly interface to streamline drug design efforts by experts and non-expert users.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Lyster, Peter
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Scripps Research Institute
La Jolla
United States
Zip Code
Kanaji, Sachiko; Orje, Jennifer N; Kanaji, Taisuke et al. (2018) Humanized GPIb?-von Willebrand factor interaction in the mouse. Blood Adv 2:2522-2532
Mortenson, David E; Brighty, Gabriel J; Plate, Lars et al. (2018) ""Inverse Drug Discovery"" Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates. J Am Chem Soc 140:200-210
Hacker, Stephan M; Backus, Keriann M; Lazear, Michael R et al. (2017) Global profiling of lysine reactivity and ligandability in the human proteome. Nat Chem 9:1181-1190
Serrano, Pedro; Aubol, Brandon E; Keshwani, Malik M et al. (2016) Directional Phosphorylation and Nuclear Transport of the Splicing Factor SRSF1 Is Regulated by an RNA Recognition Motif. J Mol Biol 428:2430-2445
Fiore, Mario; Forli, Stefano; Manetti, Fabrizio (2016) Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials. J Med Chem 59:3609-34
Backus, Keriann M; Correia, Bruno E; Lum, Kenneth M et al. (2016) Proteome-wide covalent ligand discovery in native biological systems. Nature 534:570-4
Forli, Stefano; Huey, Ruth; Pique, Michael E et al. (2016) Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc 11:905-19
Bianco, Giulia; Forli, Stefano; Goodsell, David S et al. (2016) Covalent docking using autodock: Two-point attractor and flexible side chain methods. Protein Sci 25:295-301
Perryman, Alexander L; Yu, Weixuan; Wang, Xin et al. (2015) A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA. J Chem Inf Model 55:645-59
Forli, Stefano; Olson, Arthur J (2015) Computational challenges of structure-based approaches applied to HIV. Curr Top Microbiol Immunol 389:31-51

Showing the most recent 10 out of 37 publications